Literature DB >> 11955593

A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors.

Jeffrey C Boyington1, Peter D Sun.   

Abstract

Killer cell immunoglobulin-like receptors (KIR) play a critical role in the regulation of natural killer (NK) cell activity through their recognition of class I MHC molecules expressed on target cells. KIR recognition provides vital information to NK cells about whether a target cell should be lysed or spared. Understanding the molecular mechanism of this recognition has remained a strong focus of investigation. This has resulted in the crystal structures of several members of the KIR family and more recently the determinations of the three dimensional structures of KIR2DL2 and KIR2DL1 complexed with their respective ligands, HLA-Cw3 and HLA-Cw4. A strong structural conservation has been revealed both in the receptor design and in the overall mode of KIR binding to class I molecules. Nevertheless, distinct differences in the receptor binding sites allow for high specificity between ligands. Furthermore, unexpected similarities with T-cell receptor (TCR) recognition of MHC molecules are also observed. The detailed interactions between KIR and HLA-C molecules and their functional implications will be reviewed here.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955593     DOI: 10.1016/s0161-5890(02)00030-5

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  63 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

3.  Two Orangutan Species Have Evolved Different KIR Alleles and Haplotypes.

Authors:  Lisbeth A Guethlein; Paul J Norman; Corinne M C Heijmans; Natasja G de Groot; Hugo G Hilton; Farbod Babrzadeh; Laurent Abi-Rached; Ronald E Bontrop; Peter Parham
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

Review 4.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

5.  Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?

Authors:  Rasmi Thomas; Eriko Yamada; Galit Alter; Maureen P Martin; Arman A Bashirova; Paul J Norman; Marcus Altfeld; Peter Parham; Stephen K Anderson; Daniel W McVicar; Mary Carrington
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 6.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

7.  Self/nonself perception, reproduction and the extended MHC.

Authors:  Andreas Ziegler; Pablo Sandro Carvalho Santos; Thomas Kellermann; Barbara Uchanska-Ziegler
Journal:  Self Nonself       Date:  2010-06-21

Review 8.  HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?

Authors:  Marie-Eve Blais; Tao Dong; Sarah Rowland-Jones
Journal:  Immunology       Date:  2011-03-01       Impact factor: 7.397

Review 9.  Co-evolution of MHC class I and variable NK cell receptors in placental mammals.

Authors:  Lisbeth A Guethlein; Paul J Norman; Hugo G Hilton; Peter Parham
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

10.  Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates.

Authors:  Ryotaro Nakamura; Nademanee Auayporn; David D Smith; Joycelynne Palmer; Joel Y Sun; Jeffrey Schriber; Vinod Pullarkat; Pablo Parker; Roberto Rodriguez; Anthony Stein; Joseph Rosenthal; Shirong Wang; Chatchada Karanas; Karl Gaal; David Senitzer; Stephen J Forman
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.